Literature DB >> 12593610

Use of proton magnetic resonance spectroscopy of the brain to differentiate gliomatosis cerebri from low-grade glioma.

Damien Galanaud1, Olivier Chinot, François Nicoli, Sylviane Confort-Gouny, Yann Le Fur, Maryline Barrie-Attarian, Jean-Philippe Ranjeva, Stéphane Fuentès, Patrick Viout, Dominique Figarella-Branger, Patrick J Cozzone.   

Abstract

OBJECT: Gliomatosis cerebri (GC), a rare entity characterized by a widespread infiltration of brain by tumor, lacks objective and quantitative diagnostic criteria. Single-voxel spectroscopy and chemical shift imaging (two-dimensional proton magnetic resonance [MR] spectroscopy) were performed using both short (20- or 22-msec) and long (135-msec) echo times in nine patients suffering from GC, nine patients with low-grade gliomas (LGGs), and 25 healthy volunteers to establish the precise metabolic pattern of this uncommon brain neoplasm.
METHODS: The gliomatosis infiltration was characterized by markedly elevated levels of creatine-phosphocreatine (Cr) and mvo-inositol (Ins), a reduced level of N-acetyl aspartate (NAA), and a moderately elevated level of choline-containing compounds (Cho). This pattern differs strikingly from LGGs, which are characterized by elevated levels of Cho and Ins, markedly reduced levels of NAA, and low-to-normal Cr concentrations. Although the distinction between GC and LGG, based on histological and MR imaging criteria, is a matter of debate, MR spectroscopy produces valuable information for the differentiation between these two entities and, hence, the choice of therapeutic strategy. It also provides new insight into the pathophysiology of GC because elevated Cr and Ins levels may be related to proliferation of glial elements or, more probably, activation of normal glia. Elevated levels of Cho reflect cellular proliferation and reduced NAA corresponds to reversible neuronal injury and/or focal invasion by the tumor process.
CONCLUSIONS: Owing to the unfavorable clinical outcome associated with GC compared with that associated with LGG, the findings of this study illustrate the diagnostic and prognostic value of proton MR spectroscopy in the characterization of infiltrating gliomas.

Entities:  

Mesh:

Year:  2003        PMID: 12593610     DOI: 10.3171/jns.2003.98.2.0269

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  22 in total

1.  Stripe-like increase of rCBV beyond the visible border of glioblastomas: site of tumor infiltration growing after neurosurgery.

Authors:  Stella Blasel; Kea Franz; Hanns Ackermann; Stefan Weidauer; Friedhelm Zanella; Elke Hattingen
Journal:  J Neurooncol       Date:  2010-10-07       Impact factor: 4.130

2.  Glial neoplasms without elevated choline-creatine ratios.

Authors:  Brian C Bowen
Journal:  AJNR Am J Neuroradiol       Date:  2003-05       Impact factor: 3.825

3.  Gliomatosis cerebri: a review.

Authors:  Roberta Rudà; Luca Bertero; Marc Sanson
Journal:  Curr Treat Options Neurol       Date:  2014-02       Impact factor: 3.598

4.  Spatially quantifying microscopic tumor invasion and proliferation using a voxel-wise solution to a glioma growth model and serial diffusion MRI.

Authors:  Benjamin M Ellingson; Peter S LaViolette; Scott D Rand; Mark G Malkin; Jennifer M Connelly; Wade M Mueller; Robert W Prost; Kathleen M Schmainda
Journal:  Magn Reson Med       Date:  2010-11-30       Impact factor: 4.668

Review 5.  Gliomatosis cerebri in young patients' report of three cases and review of the literature.

Authors:  Alessandro Landi; Manolo Piccirilli; Cristina Mancarella; Felice Giangaspero; Maurizio Salvati
Journal:  Childs Nerv Syst       Date:  2010-04-08       Impact factor: 1.475

6.  Lack of choline elevation on proton magnetic resonance spectroscopy in grade I-III gliomas.

Authors:  Sanjeev Chawla; Seung-Cheol Lee; Suyash Mohan; Sumei Wang; MacLean Nasrallah; Arastoo Vossough; Jaroslaw Krejza; Elias R Melhem; S Ali Nabavizadeh
Journal:  Neuroradiol J       Date:  2019-05-03

7.  Brain anomalies in maternally inherited diabetes and deafness syndrome.

Authors:  I Fromont; F Nicoli; R Valéro; O Felician; B Lebail; Y Lefur; J Mancini; V Paquis-Flucklinger; P J Cozzone; Bernard Vialettes
Journal:  J Neurol       Date:  2009-06-18       Impact factor: 4.849

8.  High cerebral scyllo-inositol: a new marker of brain metabolism disturbances induced by chronic alcoholism.

Authors:  A Viola; F Nicoli; B Denis; S Confort-Gouny; Y Le Fur; J-P Ranjeva; P Viout; P J Cozzone
Journal:  MAGMA       Date:  2004-08-31       Impact factor: 2.310

9.  Prognostic value of choline and creatine in WHO grade II gliomas.

Authors:  Elke Hattingen; Peter Raab; Kea Franz; Heiner Lanfermann; Matthias Setzer; Rüdiger Gerlach; Friedhelm E Zanella; Ulrich Pilatus
Journal:  Neuroradiology       Date:  2008-06-04       Impact factor: 2.804

Review 10.  In vivo magnetic resonance spectroscopy: basic methodology and clinical applications.

Authors:  Marinette van der Graaf
Journal:  Eur Biophys J       Date:  2009-08-13       Impact factor: 1.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.